e.g. mhealth
Search Results (1 to 10 of 48 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 12 JMIR Formative Research
- 11 JMIR Research Protocols
- 8 Journal of Medical Internet Research
- 6 JMIR Public Health and Surveillance
- 2 JMIR Medical Informatics
- 2 JMIR Perioperative Medicine
- 2 JMIR Serious Games
- 2 JMIR mHealth and uHealth
- 1 JMIR Human Factors
- 1 JMIR Pediatrics and Parenting
- 1 Online Journal of Public Health Informatics
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Aging
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 JMIR XR and Spatial Computing (JMXR)
Public Health Discussions on Social Media: Evaluating Automated Sentiment Analysis Methods
Marijuana, for example, can be discussed as a gateway drug (negative sentiment) and also from a harm reduction perspective as a substitute for opioids and other harmful street drugs (positive sentiment). Classifying the data by sentiment enables researchers to explore diverse perspectives of the digital public, potentially leading to health policy insights.
JMIR Form Res 2025;9:e57395
Download Citation: END BibTex RIS
One of the greatest risk factors for a fatal overdose is experiencing a nonfatal overdose involving opioids (NFOO) in the previous year. Indeed, 6% to 10% of individuals who experience an NFOO die in the following year [3-5]. Survivors of NFOOs most commonly die of another overdose (67%) [3], with the highest risk period being the month following NFOO [5]. Interventions that reduce the risk of a subsequent overdose among NFOO survivors would substantially impact premature mortality.
JMIR Res Protoc 2024;13:e60277
Download Citation: END BibTex RIS
The United States is in an opioid epidemic originally partially fueled by legitimate but inappropriate rates of opioid prescriptions [1-4], with additional waves associated with nonprescription opioids [5]. Reducing inappropriate opioid prescribing by health care providers is a key element of mitigating the risk of long-term opioid use and potential dependence for patients [6-10].
JMIR Hum Factors 2024;11:e44662
Download Citation: END BibTex RIS
Opioids, either obtained illicitly or as a prescription, accounted for approximately 75% of the total drug overdose deaths in 2020 [1,2]. Recent numbers suggest an acceleration of both drug and opioid overdose deaths during the COVID-19 pandemic, with the United States experiencing the largest number of drug overdose deaths during this period (93,300 deaths) compared to that reported in any given year within the last 2 decades.
Online J Public Health Inform 2024;16:e52686
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Users' Acceptability and Perceived Efficacy of mHealth for Opioid Use Disorder: Scoping Review
Excess levels of opioids may lead to respiratory depression and cardiopulmonary failure, resulting in loss of consciousness and death [3,4]. It is treated with naloxone, an antagonist that prevents opioid-related fatalities [5,6]. Thus, it is essential to find ways to manage opioid use disorder (OUD) and prevent overdose. A study reviewing smartphone apps that were commercially available until 2019 found that there was a lack of evidence on their ability to be useful for monitoring OUD [7].
JMIR Mhealth Uhealth 2024;12:e49751
Download Citation: END BibTex RIS
Even before the formal declaration of a public health emergency around opioids, the Department of Health and Human Services included expanded use and distribution of naloxone in its 3 priority areas to address the overdose epidemic [8].
JMIR Res Protoc 2024;13:e57280
Download Citation: END BibTex RIS
In the state of Indiana, where this study was conducted, preliminary data indicate 2250 overdose deaths in 2022 [5], around 71% of which involved fentanyl or other synthetic opioids [5].
Naloxone, an opioid antagonist, works by blocking the effects of opioids and can allow persons who have overdosed to resume normal breathing [6]. It is a safe and effective way to rapidly reverse the effects of opioid overdose and can prevent death [6,7].
JMIR Form Res 2024;8:e54077
Download Citation: END BibTex RIS
Although more rare, opioid overdoses can occur (256 per 100,000 person-years among people recently prescribed opioids vs 36 per 100,000 years among those not prescribed opioids) [23,24]. In studies of noncancer pain, opioid-related harms are consistently related to both ingestion of high-dose opioids (ie, >90 mg morphine equivalents) and coprescription of sedating medications (benzodiazepines and gabapentin) [25-28].
JMIR Res Protoc 2024;13:e54953
Download Citation: END BibTex RIS
When exposure to opioids ends, neonates may develop withdrawal symptoms [1]. Neonatal abstinence syndrome (NAS), also referred to as neonatal opioid withdrawal syndrome, can be subdivided into primary NAS due to prenatal opioid abuse by (or treatment of) the mother, and iatrogenic NAS (i NAS) when neonates are treated with opioids. Primary NAS may develop in more than 90% of infants after intrauterine opiate exposure [2].
JMIR Pediatr Parent 2024;7:e50575
Download Citation: END BibTex RIS